Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome

Clinical trial NCT00542269 · TERMINATED

Trial details

NCT number: NCT00542269
Sponsor: Novartis
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension With Metabolic Syndrome

Start date: 2008-03-01
Primary completion: 2009-07-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.